Kramer EL - Search Results

1

Initial clinical evaluation of radiolabeled MX-DTPA humanized BrE-3 antibody in patients with advanced breast cancer.

Kramer EL, Liebes L, Wasserheit C, Noz ME, Blank EW, Zabalegui A, Melamed J, Furmanski P, Peterson JA, Ceriani RL. Kramer EL, et al. Clin Cancer Res. 1998 Jul;4(7):1679-88. Clin Cancer Res. 1998. PMID: 9676842

2

Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts.

Ng B, Kramer E, Liebes L, Wasserheit C, Hochster H, Blank E, Ceriani R, Furmanski P. Ng B, et al. Cancer Res. 2001 Apr 1;61(7):2996-3001. Cancer Res. 2001. PMID: 11306478

3

Radioimmunolocalization of breast cancer using BrE-3 monoclonal antibody.

Kramer EL, DeNardo SJ, Liebes L, Noz ME, Kroger L, Glenn SD, Furmanski P, Ceriani R. Kramer EL, et al. Adv Exp Med Biol. 1994;353:181-92. doi: 10.1007/978-1-4615-2443-4_17. Adv Exp Med Biol. 1994. PMID: 7985537 Clinical Trial. No abstract available.

4

Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab' fragment. Preliminary results.

Kramer EL, Noz ME, Liebes L, Murthy S, Tiu S, Goldenberg DM. Kramer EL, et al. Cancer. 1994 Feb 1;73(3 Suppl):890-5. doi: 10.1002/1097-0142(19940201)73:3+<890::aid-cncr2820731321>3.0.co;2-1. Cancer. 1994. PMID: 8306275

5

Radioimmunolocalization of metastatic breast carcinoma using indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: phase I study.

Kramer EL, DeNardo SJ, Liebes L, Kroger LA, Noz ME, Mizrachi H, Salako QA, Furmanski P, Glenn SD, DeNardo GL, et al. Kramer EL, et al. J Nucl Med. 1993 Jul;34(7):1067-74. J Nucl Med. 1993. PMID: 8315480 Free article. Clinical Trial.

6

CT-SPECT fusion for analysis of radiolabeled antibodies: applications in gastrointestinal and lung carcinoma.

Kramer EL, Noz ME. Kramer EL, et al. Int J Rad Appl Instrum B. 1991;18(1):27-42. doi: 10.1016/0883-2897(91)90043-k. Int J Rad Appl Instrum B. 1991. PMID: 2010302 Review.

7

Stratifying differences on ictal/interictal subtraction SPECT images.

Koo CW, Devinsky O, Hari K, Balasny J, Noz ME, Kramer EL. Koo CW, et al. Among authors: kramer el. Epilepsia. 2003 Mar;44(3):379-86. doi: 10.1046/j.1528-1157.2003.29402.x. Epilepsia. 2003. PMID: 12614394 Free article.

8

Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer.

Schettino CJ, Kramer EL, Noz ME, Taneja S, Padmanabhan P, Lepor H. Schettino CJ, et al. Among authors: kramer el. AJR Am J Roentgenol. 2004 Aug;183(2):519-24. doi: 10.2214/ajr.183.2.1830519. AJR Am J Roentgenol. 2004. PMID: 15269050

9

CT-SPECT fusion to correlate radiolabeled monoclonal antibody uptake with abdominal CT findings.

Kramer EL, Noz ME, Sanger JJ, Megibow AJ, Maguire GQ. Kramer EL, et al. Radiology. 1989 Sep;172(3):861-5. doi: 10.1148/radiology.172.3.2788895. Radiology. 1989. PMID: 2788895

10

Fusion of immunoscintigraphy single photon emission computed tomography (SPECT) with CT of the chest in patients with non-small cell lung cancer.

Katyal S, Kramer EL, Noz ME, McCauley D, Chachoua A, Steinfeld A. Katyal S, et al. Among authors: kramer el. Cancer Res. 1995 Dec 1;55(23 Suppl):5759s-5763s. Cancer Res. 1995. PMID: 7493342

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters